
Chinese genetic engineering pharmaceutical company registered in Shenzhen on 22 April 1997 and based in the Nanshan high-tech park, developing and producing recombinant protein medicines. Among the first hundred Chinese companies to obtain GMP certification, with more than 100 million yuan of total investment, and since 2007 a member of the Hong Kong listed Union Medical Healthcare (Liankang Bio) group. Its therapeutic biologicals include recombinant human epidermal growth factor external solution and recombinant human epidermal growth factor derivative eye drops.
Xem hồ sơ công ty
Để lại đánh giá